Joseph Dicesare

Joseph Dicesare is the current President & Chief Strategy Officer at Genesis Research. Joseph has also served as the VP & Global Head of Real World Evidence & Modeling at Allergan from April 2018 to June 2020. Prior to that, they were the U.S. Head of Health Economics & Outcomes Research - Early Development at Novartis from January 1999 to March 2018. Joseph started their career in 1989 as the Director of Health Economics & Outcomes Research at Sandoz Pharmaceuticals Corp., where they worked for 10 years.

Joseph Dicesare attended Rutgers University for their Masters in Public Health (MPH) in Epidemiology and Rutgers College of Pharmacy for their Bachelor of Science - BS in Pharmacy.

Joseph Dicesare works with Michael Livingstone - Chief People Officer, Susan Oliveria - Chief Scientific Officer, and Alistair Curry - EVP & Head, Market Access Solutions. Joseph Dicesare reports to Frank A. Corvino, CEO.